Repligen Corporation (RGEN)
After hours:
- GlobeNewswire
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
Signs 15-year Strategic Collaboration and Exclusive License AgreementWALTHAM, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership and exclusive license agreement with DRS Daylight Solutions to expand the use of mid-infrared (mid-IR) technology in the bioprocessing market. Through this agreement, Repligen will assume responsibility for the c
- Zacks
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Motley Fool
Checking In on 10 Stock Picks
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. David Gardner: Thirty separate times, about every 10 weeks on this podcast over six years, I picked five stocks.
